Improvements in blood sugar, triglycerides, and blood pressure begin within weeks and often persist as long as treatment continues
Proper storage and handling practices help preserve product integrity, stability, and overall quality
Adjusting for other parameters separately did not significantly alter the estimated effects of semaglutide on PCS and MCS
A common pathway is semaglutide as an introduction, tirzepatide for patients who plateau or want stronger results, and retatrutide for patients who plateau on tirzepatide
Semaglutide showed promise in managing PCOS-related obesity, insulin resistance, and demonstrated renoprotective effects in diabetics and chronic kidney disease (CKD)
The TRIUMPH-4 data are part of an ongoing Phase III program, and regulatory submissions to the FDA and other agencies have not yet been completed